IAMPHENOM Europe 2026 Registration Opens: HR’s Leading Conference for Agentic AI Learning Returns

20.5.2026 13:00:00 CEST | Business Wire | Press Release

Phenom, the leader in applied AI with an infrastructure built specifically to redesign work operations, today announced registration is open for IAMPHENOM Europe 2026, taking place 4-5 November in Paris, France. The only applied AI event dedicated to human resources on the continent, IAMPHENOM Europe gives HR and HRIT leaders the agentic AI strategies, instruction and proof points they need to build their AI-augmented workforce to address their biggest hiring, development and retention challenges.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520683492/en/

Phenom today announced registration is open for IAMPHENOM Europe 2026. The only applied AI event dedicated to human resources on the continent is taking place 4-5 November in Paris, France.

European organisations face pressure from every direction, including widening skills shortages, tightening EU AI Act compliance and competitors moving faster with AI than HR teams can match. Most European CHROs know where they need to go, but lack the operating model to get there; a gap that averages 12 to 18 months and compounds every quarter. Generic AI tools exacerbate the problem, delivering speed without the governance or contextual precision enterprises require. IAMPHENOM Europe exists to equip European HR leaders with the agentic AI strategies, proof points and plans to redesign how their workforce operates across talent acquisition and management.

At the in-person event, HR professionals, talent acquisition leaders, HRIT teams and C-suite executives will experience two days of immersive AI learning and networking in Paris. Attendees will gain actionable strategies from the organisations already using AI and automation to improve work operations and strengthen hiring, development and retention, while connecting with peers navigating the same challenges across Europe.

IAMPHENOM Europe Highlights

Visionary Keynotes: Hear from HR leaders, industry analysts and technology experts at the forefront of applying AI and transforming their teams
Practitioner-led Sessions: Learn how talent teams at world-class organisations are solving real hiring, development and retention challenges with AI, agents and automation, while maintaining compliance across evolving European markets
Live AI Agent Demonstrations: See use-case specific AI agents in action and explore how they can be deployed across an organisation’s talent operations
Tech Unveilings & Innovation: Discover how WorkOps leverages AI and automation to redesign work during product keynotes and immersive experiences
AI & Automation Learning Lab with Agent Center: Test AI, agents and automation across 25+ use cases mapped to the hypercell level for specific job roles, industries and geographies
Expert Access: Connect directly with the Phenom team to explore advanced capabilities and discuss implementation and future-proof talent strategies
Peer Networking: Build relationships with peers and leaders navigating the same talent challenges across Europe, with dedicated networking throughout the day

“The HR leaders shaping Europe’s next decade are not asking whether to use AI, they’re already figuring out how, where and how fast, knowing the window to redesign work is closing quickly,” said Jonathan Dale, Vice President and General Manager, Global Marketing at Phenom. “IAMPHENOM Europe is where leaders learn to deploy AI, agents and automation to rebuild hiring, development and retention workflows for the new way of work. Attendees will leave with the agentic playbook to act on, drawn from the leading organisations already operating this way.”

The Practical Playbook for Europe’s Biggest Hiring & Development Challenges for Europe
IAMPHENOM Europe 2026 is designed around the specific AI and talent challenges facing organisations across the region, including European regulatory compliance, internal talent development and large-scale recruiter productivity. Session topics include how to:

Orchestrate AI agents, automation and human judgement across talent operations without manual intervention at every step
Uphold compliance and data governance while navigating European regulations
Develop and retain internal talent while attracting critical external skills
Drive recruiter productivity through automation and intelligent sourcing
Enhance employee onboarding experiences at scale

Join IAMPHENOM’s All-Star Speaker Lineup: Call for Speakers is Open
IAMPHENOM invites HR professionals, talent leaders, industry analysts and technology experts to submit speaker proposals to share their expertise, inspire peers and join a distinguished roster of presenters. Apply at iamphenomeurope.com/speakersby July 17.

Register and Learn More
Register for €26 (nearly 90% savings) for a limited time. Register and learn more at iamphenomeurope.com.

About Phenom
Phenom is an applied AI company with the only AI infrastructure built specifically for HR. Powered by Engines that harmonize data, Ontologies that guide every decision, X AI that hyper-personalizes experiences, and Agents that work alongside teams, Phenom’s platform uses industry and business context to automate workflows, eliminate busywork, and enhance every experience while remaining compliant. Driven by a purpose to help a billion people find the right work, no other company is as dedicated to helping organizations hire faster, develop better and retain longer.

Phenom has earned accolades including: Inc. 5000’s fastest-growing companies (6 consecutive years), Deloitte Technology's Fast 500 (5 years), 11 Brandon Hall ‘Excellence in Technology’ awards including Gold for ‘Best Advance in Generative AI for Business Impact,’ Business Intelligence Group’s Artificial Intelligence Excellence Awards (3 consecutive years), The Cloud Awards 2025/2024, The A.I. Awards 2024, and a regional Timmy Award for launching and optimizing HelpOneBillion.com (2020).

Headquartered in Greater Philadelphia, Phenom also has offices in Canada, India, Israel, the Netherlands, Germany and the United Kingdom.

For more information, please visit www.phenom.com. Connect with Phenom on LinkedIn, X, Facebook, YouTube, Instagram and TikTok.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260520683492/en/

Contacts

Jennifer Lyons
Phenom
267-379-5066
jennifer.lyons@phenom.com

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press Release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press Release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press Release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict

Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press Release

A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal opportunities across the Group’s production sites and communities. These are just some of the “sustainability” stories the Barilla Group is sharing on World Environment Day with the publication of its 2025 Sustainability Report. The report comes just after Barilla was named the world’s most reputable company in the food sector for the third year running and, for the first time, ranked among the global top 10 in the Global RepTrak 100 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603162436/en/ “The future of the planet will increasingly depend on our ability to spread culture and education,” says Paolo Barilla, Vic

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom